Oyster Point Pharma, Inc.
(NASDAQ) OYST
This security has been delisted. This page is retained for historical reference.
OYST News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowOYST Financials
Key Financial Metrics (TTM)
Gross Margin
93.79%
Operating Margin
-394.98%
Net Income Margin
-425.42%
Return on Equity
-72.95%
Return on Capital
-50.41%
Return on Assets
-46.89%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$15.07M
Operating Income
-$164.32M
EBITDA
-$164.01M
Operating Cash Flow
-$165.98M
Capital Expenditure
-$438.00K
Free Cash Flow
-$166.42M
Cash & ST Invst.
$68.80M
Total Debt
$94.72M
Oyster Point Pharma, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$5.59M
-68.8%
Gross Profit
$4.24M
-76.4%
Gross Margin
75.89%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
303
N/A
Net Income
-$40.24M
-127.7%
EBITDA
-$33.18M
-101.0%
Quarterly Fundamentals
Total Cash
$68.80M
-62.6%
Total Debt
$94.72M
+122.5%
Accounts Receivable
$13.18M
+427.4%
Inventory
$6.96M
N/A
Long Term Debt
$94.03M
+123.4%
Short Term Debt
$692.00K
+43.9%
Return on Assets
-46.89%
N/A
Return on Invested Capital
-50.01%
N/A
Free Cash Flow
-$35.97M
-225.1%
Operating Cash Flow
-$35.97M
-232.8%